Discover 999 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 999
A Study Of Milk Consumption In Metabolic Syndrome
for
Metabolic Syndrome
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 70
Code: NCT07401888
Recruiting
Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors
for
Metastatic Malignant Skin Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07062003
Recruiting
A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients
for
Known or Highly Suspected Central Nervous System (CNS) Lesion,
Location: Rochester MN, The Woodlands TX
Sponsor: GE Healthcare
Sex: All
Age: 18+
Code: NCT07472491
Phase 2, Phase 3, Recruiting
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Rochester MN, Iowa City IA, Milwaukee WI, Omaha NE,
Sponsor: CellCentric Ltd.
Sex: All
Age: 18+
Code: NCT07096778
Phase 2, Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Rochester MN, Toronto, Fairfax VA, Washington D.C. DC,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT07154706
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
for
Glioblastoma, IDH-Wildtype,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07301268
Phase 2, Recruiting
Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice:
for
Pharmacogenomic Drug Interaction, Side Effect of Drug,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06322238
Phase 2, Recruiting
Real World Observational Study of Sotatercept for Pulmonary Hypertension
for
Pulmonary Hypertension
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06751082
Recruiting
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
for
Esophageal Squamous Cell Carcinoma
Location: Rochester MN, Kansas City MO, Detroit MI, Nashville TN,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06644781
Phase 3, Recruiting
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
for
Von Willebrand Disease (VWD),
Location: Rochester MN, Indianapolis IN, Ann Arbor MI,
Sponsor: Hemab ApS
Sex: All
Age: 16+
Code: NCT06610201
Recruiting
Minnesota RETAIN Phase 3
for
Injuries Related Work, Illness Related Work, Disability
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07037927
Recruiting
E-Mindfulness Approaches for Living After Breast Cancer
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Rochester MN, Melrose Park IL, Maywood IL, Chicago IL,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07000084
Phase 3, Recruiting
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for
Moderate Aortic Valve Stenosis
Location: Rochester MN, Elk Grove Village IL, Naperville IL,
Sponsor: Kardigan, Inc.
Sex: All
Age: 50+
Code: NCT07001800
Phase 2, Phase 3, Recruiting
The PeriCut Catheter System Early Feasibility Study (REIMAGINE-HFpEF)
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma